Nursing care
Ondansetron: what to check before you give it
Written and reviewed by Dana Whitfield, RN, MSN · 4 min read · Updated September 2026
Short answer
Ondansetron is a 5-HT3 antagonist used to prevent and treat nausea and vomiting, most often before chemotherapy, after surgery, or in hyperemesis. The nursing priority is QT prolongation, not the headache patients usually notice first. Check baseline ECG risk factors, give it before the emetogenic trigger rather than after, and watch for additive QT effects with other drugs.
Mechanism, simply
Ondansetron blocks serotonin (5-HT3) receptors, both peripherally on vagal nerve terminals in the gut and centrally in the chemoreceptor trigger zone of the medulla. Chemotherapy and surgery both release serotonin from enterochromaffin cells in the gut wall, and that serotonin is what triggers the vomiting reflex. By sitting on the 5-HT3 receptor, ondansetron stops that signal from reaching the brainstem.
It does nothing for motion sickness or most other causes of nausea, because those pathways don't run through serotonin in the same way. That's a useful distinction to hold onto: ondansetron is a targeted blocker, not a general antiemetic, and picking it for the wrong mechanism of nausea is a common exam distractor.
Indications you will see on the ward
The classic use is chemotherapy-induced nausea and vomiting, and this is where timing matters most. Ondansetron works better given before the chemotherapy than after, because it needs to occupy the 5-HT3 receptors ahead of the serotonin surge rather than compete with it once vomiting has already started. Standard practice is IV administration roughly 30 minutes before the infusion begins.
You'll also see it for postoperative nausea and vomiting, given intraoperatively or on emergence, and for hyperemesis gravidarum, where it's used cautiously and typically after other options have been tried. Some units use it for gastroenteritis-related vomiting in both adults and children, off-label in many jurisdictions, so check local protocol before assuming it's first-line there.
Assessment before administration
Check the baseline ECG and QTc if one is available, and review electrolytes, specifically potassium and magnesium, since hypokalemia and hypomagnesemia both lower the threshold for QT-related arrhythmia. A patient with a personal or family history of long QT syndrome needs closer scrutiny before this drug goes in.
Ask about other QT-prolonging medications on the chart, ask about liver disease since ondansetron is hepatically metabolised, and confirm the indication actually fits a serotonin-mediated cause of nausea rather than something else. Document baseline vital signs, particularly heart rate and rhythm if telemetry is in place, so any change after administration has something to compare against.
Toxicity and the antidote
There is no specific antidote for ondansetron toxicity. Management is supportive: stop the drug, correct any electrolyte abnormality driving the QT prolongation, and monitor rhythm closely, escalating to continuous cardiac monitoring if torsades de pointes develops or the QTc is significantly prolonged.
Serotonin syndrome is a second toxicity to keep on your radar, particularly when ondansetron is combined with other serotonergic drugs. Watch for agitation, hyperreflexia, clonus, and autonomic instability, and treat by stopping the offending agents and providing supportive care rather than a single reversal agent.
Interactions that matter
The interaction the exam wants you to catch is with other QT-prolonging drugs: haloperidol, certain antipsychotics, some antiarrhythmics like amiodarone, and macrolide antibiotics such as erythromycin. Stacking any of these with ondansetron compounds cardiac risk, and it's the combination, not ondansetron alone, that most often tips a patient into a dangerous rhythm.
Apomorphine is contraindicated with ondansetron because the combination has caused profound hypotension and loss of consciousness. Tramadol is another one to flag, since ondansetron can blunt its analgesic effect while also raising serotonin syndrome risk when other serotonergic agents are on board.
What the patient must be told
Tell the patient that headache is the most common side effect, and that it's usually mild and manageable with routine analgesia rather than a reason to stop the drug. Constipation is the other frequent complaint, so encourage fluids and mobility where the patient's condition allows.
Ask the patient to report palpitations, dizziness, or fainting, since these can signal a cardiac rhythm problem rather than ordinary drug side effects. If they're on other medications at home, particularly anything for depression, migraines, or heart rhythm, make sure that's flagged before ondansetron is added to the regimen.
The next step on this is the same as on everything else here: answer questions and read the rationales. Our pharmacology practice questions are the closest set to what this page covers.
One question from the pharmacology set
A client with heart failure is started on furosemide 40 mg PO daily. Which findings should the nurse report to the provider before administering the next dose? Select all that apply.
Rationale
Furosemide is a loop diuretic, so the two things you are watching are potassium and kidney function. A potassium of 2.9 mEq/L is below the 3.5–5.0 reference range and puts the client at risk for dysrhythmia — hold and report. Muscle cramps with palpitations are the clinical face of that same hypokalemia, so they are reported together, not separately. A creatinine that doubles signals the diuresis has outrun renal perfusion. A blood pressure of 132/78 and a 1 kg loss are the expected response to the drug working, not reasons to hold it.
Answer: A, D, E
Common questions
Can ondansetron cause QT prolongation at normal doses?
Yes, and this risk is dose-related but not exclusive to high doses. It's why IV ondansetron doses above certain thresholds are now capped in many protocols, and why the FDA restricted the single IV dose used for chemotherapy-induced nausea in adults.
Why give ondansetron before chemotherapy instead of after nausea starts?
It blocks the 5-HT3 receptors before the serotonin surge from cell damage occurs, which is far more effective than trying to displace serotonin that's already bound once vomiting has begun. Pre-treatment, typically 30 minutes before the infusion, is standard practice for this reason.
Is ondansetron safe in pregnancy?
It's used for hyperemesis gravidarum but the data on first-trimester safety are mixed, with some studies suggesting a small increase in certain birth defects. Many providers reserve it for cases where other antiemetics have failed, and this should always be an individualised prescribing decision, not a nursing one.
What's the difference between ondansetron's common side effect and its serious adverse effect?
Headache and constipation are the common, low-risk effects patients report most. QT prolongation and the associated arrhythmia risk are the adverse effect that requires monitoring and is the one tested on the NCLEX, because it's less obvious to the patient but more dangerous.
More on pharmacology
Guides on this